Last reviewed · How we verify

NCT06371365

Adverse Events for Free Flap Surgery in Head and Neck Cancer

Completed Last updated 18 April 2024
What this trial tests

trial testing Free Flap surgery in Surgical Flaps in 540 participants. Completed in 24 September 2023.

Timeline
19 October 2022
Primary endpoint
24 September 2023
24 September 2023

Quick facts

Lead sponsorKaohsiung Medical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment540
Start date19 October 2022
Primary completion24 September 2023
Estimated completion24 September 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Medical University

Who can join

20 and older, any sex, with Surgical Flaps or Flap Failure Risk Factors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cohort study collecting patients with head and neck cancer who underwent free flap surgery at a single medical center between January 2019 and January 2022.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cumulative risk factors for flap failure, thrombosis, and hematoma in free flap reconstruction for head and neck cancer: a retrospective nested case-control study.
    Hsiung PH, Huang HY, Chen WY, Kuo YR, et al · · 2024 · cited 3× · PMID 39236088 · DOI 10.1097/js9.0000000000002069

Verify or expand the search:

Other Kaohsiung Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06371365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing